We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+20.64%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.69%
AUM
$925M
AUM Growth
+$432M
Cap. Flow
+$266M
Cap. Flow %
28.73%
Top 10 Hldgs %
21.37%
Holding
202
New
35
Increased
66
Reduced
37
Closed
34

Top Buys

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$16.3M
2
SDGR icon
Schrodinger
SDGR
+$16.2M
3
ARGX icon
argenx
ARGX
+$16.2M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$14.7M
5
RGEN icon
Repligen
RGEN
+$14.2M

Top Sells

Rank Stock Value
1
DKS icon
Dick's Sporting Goods
DKS
+$6.73M
2
CALY
Callaway Golf Company
CALY
+$6.16M
3
FTDR icon
Frontdoor
FTDR
+$5.3M
4
SMAR
Smartsheet Inc.
SMAR
+$4.04M
5
PZZA icon
Papa John's
PZZA
+$3.52M

Sector Composition

Rank Sector Weight
1 Healthcare 48.41%
2 Technology 11.82%
3 Consumer Discretionary 8.18%
4 Industrials 6.85%
5 Communication Services 3.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVCR icon
1
NovoCure
NVCR
$1.78B
$22.2M 2.4%
199,613
+158,817
+389% +$12.7M
ARGX icon
2
argenx
ARGX
$52B
$21.9M 2.37%
83,405
+67,170
+414% +$16.2M
IMMU
3
DELISTED
Immunomedics Inc
IMMU
$20.9M 2.26%
245,698
+146,549
+148% +$7.41M
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$20.5M 2.22%
264,356
+212,977
+415% +$14.7M
TDOC icon
5
Teladoc Health
TDOC
$1.21B
$20.5M 2.21%
93,400
+77,169
+475% +$16.3M
TWST icon
6
Twist Bioscience
TWST
$6.29B
$20.5M 2.21%
269,520
+225,697
+515% +$14.1M
RGEN icon
7
Repligen
RGEN
$8.3B
$19.2M 2.08%
130,201
+99,540
+325% +$14.2M
MYOK
8
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$17.8M 1.92%
130,321
+101,286
+349% +$10.8M
KRNT icon
9
Kornit Digital
KRNT
$734M
$17.5M 1.89%
270,154
-18,350
-6% -$1.05M
IOVA icon
10
Iovance Biotherapeutics
IOVA
$1.93B
$16.7M 1.8%
506,814
+422,298
+500% +$12.9M
CZR icon
11
Caesars Entertainment
CZR
$6.06B
$16.4M 1.77%
292,444
+108,598
+59% +$4.77M
BHVN
12
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$16.4M 1.77%
251,946
+192,988
+327% +$12.6M
TPTX
13
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$16M 1.73%
183,357
+151,978
+484% +$10.6M
NEO icon
14
NeoGenomics
NEO
$2.04B
$15.5M 1.68%
420,090
+337,725
+410% +$12.6M
VEEV icon
15
Veeva Systems
VEEV
$33.5B
$15.5M 1.67%
55,060
+52,216
+1,836% +$13.8M
MPWR icon
16
Monolithic Power Systems
MPWR
$66B
$15.5M 1.67%
55,279
-3,090
-5% -$804K
EXAS
17
DELISTED
Exact Sciences
EXAS
$15.4M 1.67%
151,512
+130,243
+612% +$11.2M
GH icon
18
Guardant Health
GH
$21.3B
$15.4M 1.67%
138,100
+122,113
+764% +$11.2M
SILK
19
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$14.7M 1.59%
219,026
+172,174
+367% +$9.4M
OSH
20
DELISTED
Oak Street Health, Inc.
OSH
$13.7M 1.48%
+256,915
New +$11.5M
INSP icon
21
Inspire Medical Systems
INSP
$1.5B
$13.7M 1.48%
106,113
+94,057
+780% +$10.4M
AXSM icon
22
Axsome Therapeutics
AXSM
$10.9B
$13.4M 1.45%
187,756
+165,355
+738% +$12.9M
LSCC icon
23
Lattice Semiconductor
LSCC
$18B
$12.6M 1.36%
435,435
-35,244
-7% -$1.04M
ITCI
24
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$11.7M 1.27%
+457,720
New +$10.4M
SDGR icon
25
Schrodinger
SDGR
$1.14B
$11.2M 1.21%
+235,823
New +$16.2M
1
2 3 4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Nicholas Investment Partners held 202 positions worth $925M, up 88% from $493M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nicholas Investment Partners deployed $266M of net new capital in Q3 2020, opening 35 new positions and adding to 66 existing holdings. Its largest new stake was Schrodinger: 235,823 shares worth $11.2M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 12% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Callaway Golf Company, an estimated $6.16M trimmed.

  • Nicholas Investment Partners's largest Q3 2020 buy was Schrodinger: 235,823 shares worth $11.2M.
  • Nicholas Investment Partners added most to Teladoc Health in Q3 2020, an estimated $16.3M increase.
  • Nicholas Investment Partners's biggest Q3 2020 reduction was Callaway Golf Company, cutting an estimated $6.16M.
  • Nicholas Investment Partners fully exited Dick's Sporting Goods in Q3 2020, selling an estimated $6.73M.
  • Nicholas Investment Partners's ten largest holdings make up 21% of its $925M portfolio in Q3 2020.
  • Nicholas Investment Partners opened 35 new positions and closed 34 in Q3 2020.
  • Nicholas Investment Partners's portfolio value rose 88% quarter-over-quarter to $925M.

Based on Nicholas Investment Partners's 13F filing for Q3 2020, filed 13 Nov 2020.